For the latest urology news releases from UroToday access

For the latest urology news releases from UroToday access,study,re Announces Publication of Phase II Proof-of – Concept Coronary TrialBiopure Corporation announced that the results from the Phase II study, coronary revascularization in the peer-reviewed journal published Euro intervention. Paper is entitled paper is entitled Proof-of-concept study of hemoglobin based oxygen therapeutics in elective percutaneous coronary revascularization to assess . Rationale, protocol design, and haemodynamic results. The manuscript by by Principal Investigator Patrick W. Serruys, MD PhD and colleagues from the Department of Interventional Cardiology, Thoraxcenter, Erasmus MC, University Medical Centre Rotterdam, The Netherlands. Biopure COR-0002 study in the Journal Euro Intervention demonstrate the possible use of Hemopure in patients with coronary heart disease, said Biopure Chairman and CEO Zafiris G. Zafirelis. Based on the effectiveness and safety of the drug in this study , we believe that Hemopure could be an oxygen bridge to permanent myocardial damage in patients maintain to prevent a heart attack. .

Biopure CorporationBiopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics intravenously administered intravenously administered to deliver oxygen to the tissues of the body. The U.S. Navy)[ hemoglobin glutamer – 250 ], or HBOC-201, is approved for sale in South Africa approved for the treatment the surgical patients who are acutely anemic. The company is developing Hemopure for other indications and support the U.S. Navy Government funded efforts to potential out-of – hospital trauma indication to develop. Biopure of veterinary medicines Oxyglobin [ hemoglobin glutamer – 200 ], or HBOC-301, the only oxygen therapeutic for marketing was approved by both the U.S. Food and Drug Administration and the European Commission, is indicated for the treatment of anemia in dogs. Biopure 200,000 units 200,000 units of of Oxyglobin since its launch in 1998.

Gee was merciful in acceptance of his prize. – ‘I recall any previous recipients and their performance, as well ones let things happen behind the scenes, and I truly humiliation,’said Gee, who is on the association of the Board of Directors and is one guy of American Academy of Optometry. ‘I have been blessed by support from family and mentors, non to patients to note my care to mention while my early career. ‘.

Identify Tom Jefferson and colleagues at Cochrane Vaccine Field Italian and evaluated 274 studies on of influenza vaccines and analyzes its methodological quality of, prestige of the host magazines and citation rates in the scientific literature.

Related Posts

Other Posts From Category "otolaryngology":